Results for tag: "Anosmia Drug"

Anosmia Drug is a type of Central Nervous System (CNS) drug used to treat anosmia, or the inability to smell. It is a relatively new class of drug, with the first approved drug being approved in 2020. Anosmia drugs are typically used to treat anosmia caused by head trauma, viral infections, or other medical conditions. They work by targeting the olfactory receptors in the brain, which are responsible for the sense of smell. Anosmia drugs are typically administered orally or intranasally, and can be used in combination with other treatments such as cognitive behavioral therapy. Common side effects of anosmia drugs include nausea, dizziness, and headaches. The Anosmia Drug market is growing rapidly, as more people are affected by anosmia due to various causes. The market is expected to continue to grow as more drugs are developed and approved for use. Some companies in the Anosmia Drug market include GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more